MASTOCYTOSIS
Clinical trials for MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for mastocytosis patients: drug trial targets debilitating symptoms
Symptom relief OngoingThis study tests an experimental drug called bezuclastinib (CGT9486) in adults with nonadvanced systemic mastocytosis, a rare disease where too many mast cells cause symptoms like flushing, itching, and stomach issues. About 237 participants will receive either the drug or a plac…
Matched conditions: MASTOCYTOSIS
Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Rare disease pregnancy study withdrawn before start
Knowledge-focused TerminatedThis study was designed to track pregnancies in women with rare autoimmune diseases like lupus, arthritis, and scleroderma. The goal was to learn about complications and improve care. However, the study was withdrawn before enrolling any participants, so no results are available.
Matched conditions: MASTOCYTOSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC